Adicet Bio Inc (NASDAQ: ACET) is -44.18% lower on its value in year-to-date trading and has touched a low of $0.45 and a high of $2.35 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ACET stock was last observed hovering at around $0.45 in the last trading session, with the day’s gains setting it 0.09%.
Currently trading at $0.54, the stock is -25.95% and -35.05% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.42 million and changing 20.11% at the moment leaves the stock -52.90% off its SMA200. ACET registered -75.02% loss for a year compared to 6-month loss of -62.18%. The firm has a 50-day simple moving average (SMA 50) of $0.82688 and a 200-day simple moving average (SMA200) of $1.140165.
The stock witnessed a -30.79% gain in the last 1 month and extending the period to 3 months gives it a -41.45%, and is -15.92% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.39% over the week and 10.36% over the month.
Adicet Bio Inc (ACET) has around 152 employees, a market worth around $44.40M and $0.00M in sales. Distance from 52-week low is 20.11% and -77.15% from its 52-week high. The company has generated returns on investments over the last 12 months (-58.35%).
The EPS is expected to shrink by -14.39% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Adicet Bio Inc (ACET) Top Institutional Holders
76.0 institutions hold shares in Adicet Bio Inc (ACET), with institutional investors hold 71.18% of the company’s shares. The shares outstanding are 82.57M, and float is at 65.36M with Short Float at 4.36%. Institutions hold 69.24% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 11.45 million shares valued at $13.85 million. The investor’s holdings represent 12.6303% of the ACET Shares outstanding. As of 2024-06-30, the second largest holder is TANG CAPITAL MANAGEMENT LLC with 8.22 million shares valued at $9.94 million to account for 9.0663 of the shares outstanding. The other top investors are RA CAPITAL MANAGEMENT, L.P. which holds 7.54 million shares representing 8.3205% and valued at over $9.12 million, while GOLDMAN SACHS GROUP INC holds 5.4171 of the shares totaling 4.28 million with a market value of $5.18 million.
Adicet Bio Inc (ACET) Insider Activity
The most recent transaction is an insider sale by Kauffman Michael, the company’s Director. SEC filings show that Kauffman Michael sold 5,900 shares of the company’s common stock on Jun 05 ’24 at a price of $1.43 per share for a total of $8437.0. Following the sale, the insider now owns 5900.0 shares.
